Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary colorectal cancer.

H T Lynch1, T C Smyrk

  • 1Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, NE 68178, USA.

Seminars in Oncology
|October 21, 1999
PubMed
Summary

Hereditary colorectal cancer (CRC) is confirmed by germ-line mutations. Despite this knowledge, many familial adenomatous polyposis patients still die from metastatic CRC, indicating a gap in clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Southwestern Athabaskan genetic diseases.

Genetics in medicine : official journal of the American College of Medical Genetics·2001
Same author

Family information service and hereditary cancer.

Cancer·2001
Same author

Current status of prophylactic surgery for hereditary breast and gynecologic cancers.

Current opinion in obstetrics & gynecology·2001
Same author

Parental communication of BRCA1/2 genetic test results to children.

Patient education and counseling·2001
Same author

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families.

Gastroenterology·2000
Same author

E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.

Cancer genetics and cytogenetics·2000

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Germ-line mutations are definitively linked to hereditary colorectal cancers (CRCs).
  • Hereditary cancer syndromes, like familial adenomatous polyposis (FAP), have been recognized for over a century.
  • Molecular advancements are refining the understanding of genetic contributions to cancer.

Purpose of the Study:

  • To assess if clinical practices have integrated the knowledge of hereditary cancer factors for patient benefit.
  • To evaluate the translation of genetic discoveries into improved patient outcomes for hereditary CRC.

Main Methods:

  • Review of existing data on hereditary cancer syndromes.
  • Analysis of clinical outcomes for patients with familial adenomatous polyposis.
  • Correlation of molecular genetic findings with clinical management strategies.

Main Results:

  • The role of genetics in cancer, specifically CRC, is unequivocally established.
  • Despite established knowledge of FAP, a significant percentage (59%) of patients succumb to metastatic CRC.
  • This suggests a disconnect between scientific understanding and clinical implementation.

Conclusions:

  • Clinical management of hereditary colorectal cancer has not fully incorporated genetic insights.
  • There is a critical need to improve the translation of genetic knowledge into patient care to reduce mortality from hereditary cancers like FAP.

Related Experiment Videos